AI assistant
PROKIDNEY CORP. — Director's Dealing 2024
Feb 6, 2024
32485_dirs_2024-02-06_405c55f8-531c-431a-936e-ebd2780c442b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2024-02-05
Reporting Person: Weber Darin J. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-05 | Class A Ordinary Shares | C | 137073 | — | Acquired | 274073 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-05 | Class B Ordinary Shares | $0 | C | 137073 | Disposed | Class A Ordinary Shares (137073) | Direct | |
| 2024-02-05 | Common Units in ProKidney LP | $0 | C | 137073 | Disposed | Class A Ordinary Shares (137073) | Direct |
Footnotes
F1: The Class B Ordinary Shares and the Common Units in ProKidney LP (a "Common Unit") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and and the Second Amended and Restated Company Partnership Agreement, each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis.
F2: The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the "Business Combination Agreement"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire.
F3: The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire.